chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This case was reported by a other health professional via call center representative and described the occurrence of occipital neuralgia in a male patient who received SHINGRIX. Concomitant products included SHINGRIX. On 2nd March 2018, the patient received the 2nd dose of SHINGRIX. On 2nd March 2018, unknown after receiving SHINGRIX, the patient experienced drug dose administration interval too short. On 15th April 2018, the patient experienced occipital neuralgia. On an unknown date, the outcome of the occipital neuralgia was not reported and the outcome of the drug dose administration interval too short was unknown. It was unknown if the reporter considered the occipital neuralgia to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. On 12th February 2018, the patient received 1st dose of SHINGRIX. On 2nd March 2018, the patient received 2nd dose of SHINGRIX earlier than the recommended schedule, which led to shortening of the vaccination schedule. The patient developed right sided occipital neuralgia. The healthcare professional did not provide his date of birth or any lot number or expiry date of the SHINGRIX dose he was given early.
Had vaccine 4/8/03. Swelling, redness and warm to touch around injection site 5.5"x6.5" in width/length.
Information has been received from a pharmacy technician concerning unspecified number of patients (pediatric and/or adolescent) who in March 2011, were vaccinated with ROTATEQ (lot # not reported), which were exposed to very low temperature within a more than 2 months (also reported as 3 months) period from 05-JAN-2011 to 18-MAR-2011. No adverse events reported. This is one of several reports from the same source. All telephone attempts to obtain follow-up information have been unsuccessful. Additional information has been requested.
headaches; fever; fatigue; This is a spontaneous report from a Pfizer sponsored program. A contactable consumer (patient's mother) reported for a 25-year-old female patient that:  A 25-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Lot number; Unknown), via an unspecified route of administration as dose 1, single on an unspecified date for covid-19 immunisation. Medical history included headaches (but increases water intake and they have resolved) from an unknown date and unknown if ongoing. Concomitant medication included tofacitinib citrate (XELJANZ; Tablet) at 10 mg taken for an unspecified indication from 26Sep2020 to an unspecified stop date. Reported patient use to get headaches but increases water intake and they have resolved. Patient received Covid-19 vaccine yesterday and has been experiencing headache, fever and fatigue on unspecified date. At the time of this report, the outcome of events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Information has been received from a physician assistant concerning a 15 year old female patient with latex allergy who on 24-APR-2008, was vaccinated with the first dose of GARDASIL 0.5ml, I.M. There was no concomitant medication. On 25-APR-2008, the patient experienced vomiting for 2 to 3 days after administration of her first dose of GARDASIL. On 27-APR-2008, the recovered from vomiting for 2 to 3 days after administration of her first dose. The patient sought for medical attention at the time physician's office. Additional information has been requested.
Left deltoid pain, swelling, and warmth.   Planned treatment is NSIADs and ice. Patient was seen today.   Outcome: TBD
Telogen Effluvium; This is a spontaneous report received from a contactable reporter(s) (Physician). The reporter is the patient.  A 41 year-old male patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 23Sep2021 (Batch/Lot number: unknown) at the age of 41 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "HTN" (unspecified if ongoing), notes: HTN. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: Unknown. Not available/provided to reporter at the time of report completion), administration date: 18Aug2021, when the patient was 40 years old, for COVID-19 Immunization. The following information was reported: DIFFUSE ALOPECIA (non-serious) with onset Nov2021, outcome "recovering", described as "Telogen Effluvium". The event "telogen effluvium" was evaluated at the physician office visit. Therapeutic measures were not taken as a result of diffuse alopecia.  Additional information: The patient was not diagnosed with COVID-19 Prior to vaccination. The patient was not tested for COVID-19 since the vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No known allergies.  The lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.
Systemic: Tingling (specify: facial area, extemities)-Severe, Additional Details: Started immediately after administration. tingling in the brain then migrated to the whole body
She tested + o 4-2-23 and passed away 7-22-23.  I have no other information.  The ordering facility for the covid test was hospital
I first noticed that a swelling about 1/2 inch long and wide suddenly popped up at my right temple. It was warm to the touch and pinkish (like a hive). When I pushed on it, it was tender to the touch. Then my right ear started itching and felt a bit not normal - perhaps swollen. It itched a lot. Then I also noticed that the swelling on my right temple extended down along the right side of my face, and eye socket, reaching my upper jaw. When I opened and closed my mouth, it seemed that I had swelling near the jaw, too.  I also felt a bit nauseous, and had chills - actually alternating chills and feeling too warm. I became a bit alarmed and called my physician's after hour line, but after talking to them decided to monitor myself and not go to the ER.  My impression was that the swelling resembled one big continuous hive. I took some Advil and rested. After about 3 hrs, the itching subsided, and when I awoke in the morning, the swelling along the side of my face had gone down. It has not returned since.
On day 12 muscle discomfort in quadriceps; discomfort in lower back; This is a spontaneous report received from a contactable consumer (patient). A 78-years-old non-pregnant female patient received bnt162b2 first dose (BNT162B2, Solution for injection, lot Number: EN5318) via an unspecified route of administration, on left arm on 30Jan2021 13:00 at single dose for an unspecified indication. Relevant medical history and concomitant medications were not provided. Since the vaccination, the patient had not tested positive for COVID-19. Patient has not had symptoms associated with COVID-19. The patient previously received sulfa [sulfadiazine] and experienced drug hypersensitivity. On 10Feb2021 12:15, the patient experienced on day 12 muscle discomfort in quadriceps and discomfort in lower back gradually worsening each day. The outcome of the events was not recovered.
Hepatic Artery Aneurysm- Pain and swelling in abdomen-11/21/22 Acute Stroke- Slurred speech, left sided paralysis- 12/31/22
stomach cramping; Nausea; vomiting /has been throwing up; being sick the next day; she haven't been eating much; weight is down a little bit, it is around 98 pounds; This is a spontaneous report from a contactable consumer or other non hcp (Patient). A 86-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE,Batch/Lot Number: CN9581) single dose via an unspecified route of administration, administered in Arm Left on 15Feb2021 for covid-19 immunisation.  Medical history included abdominal discomfort unknown if ongoing had these stomach issues before, but not for this long of a timeframe.She does have other medications, but she had not been taking them all, she had just been taking the most important ones because she does not know if they will stay down.   On 16Feb2021 the patient experienced stomach cramps, nausea, she had been throwing up, and it hurts. she haven't been eating much because she was throwing up, so her weight is down a little bit, it is around 98 pounds. she has had these stomach issues before, but not for this long of a timeframe. The patient had no other vaccines on the same day as the COVID Vaccine. The patient underwent lab tests and procedures which included weight was it is around 98 pounds lbs on down a little bit. The outcome for the events stomach cramping, Nausea and vomiting /has been throwing up were not recovered. The outcome for the events being sick the next day, she haven't been eating much and weight is down a little bit, it is around 98 pounds were unknown. No follow-up attempts are possible. No further information is expected.
Achy and tired (since onset of symptoms, approx. 8 hours after injection) Diarrhea (34 hours after injection) Soreness and swelling at injection site Lower back pain (30 hours after injection)
chills; body pain; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program.  A male patient received bnt162b2 (BNT162B2), administration date 04Aug2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: CHILLS (non-serious) with onset Aug2021, outcome "unknown", described as "chills"; PAIN (non-serious) with onset Aug2021, outcome "unknown", described as "body pain". No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Primarily periodic headaches, particularly with the second shot.  Nausea particularly with the first shot.
her arm was sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (her arm was sore) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (her arm was sore). At the time of the report, PAIN IN EXTREMITY (her arm was sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessment.  No concomitant medications were reported. Treatment information was not provided.   This case was linked to MOD-2021-155051 (Patient Link).
dizzy; vertigo; This is a spontaneous report from a contactable consumer (patient). A female patient of unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number: unknown) via an unspecified route of administration on 12Apr2021 at single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. A couple days later after vaccination patient was really dizzy like vertigo that lasted a couple of days. Is that a normal side effect,  should patient get her second dose, Is dizziness considered a very bad reaction. The outcome of the events was recovered on an unknown date in Apr2021.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
101 temperature, chills, shivering, headache, nausea, dizziness
Patient called on Wednesday 01/19/2022 and informed me that she has a lump under her left armpit, she noticed it on Tuesday(1/18/2022). Patient had gotten the Pfizer vaccine booster on Sunday 01/16/2022 and per patient she thinks it is from the vaccine. However, patient said the lump is less tender compared to yesterday (Tuesday, 01/18/2022); patient said she will reach out to her doctor if it doesn't get better. Advised patient to get it examined with her doctor.
This spontaneous report as received from a licensed nurse practitioner refers to a patient of unknown age. On an unknown date the patient was vaccinated with a dose of ZOSTAVAX (lot # not reported). ZOSTAVAX was exposed to temperature up to 24F for 67 days (1608 hours) and it was determined not viable. Improperly stored ZOSTAVAX had been administered to the patient. No adverse effects reported. This is one of several reports received from the same source (same reporter link:same reporter link: 1303USA011844 and 1304USA002220). Additional information has been requested.
58M w/ Hx CKD s/p renal Tx 2012, DM, seizures HLD adm 1/29 w/ COVID pneumonia hypoxemia- Dx 1/20 despite 2x vaccination & booster- Rx w/ dexamethasone 6mg, supplemental O2, empiric abx and admitted to med surg.  RRT today 1/30 for low SATs, he was emergently intubated & brought to the ICU.
Patient suffered a seizure and pulmonary edema four days after receiving second Pfizer shot. He was pronounced dead several hours later. Patient had no health issues and was 45 years old.
Swollen lymph nodes; Nausea; Injection site pain; Headache; Muscle and joint pain; Muscle and joint pain; This is a spontaneous report from a contactable reporter (consumer or other non-HCP). The reporter is the patient.  A 44-year-old male patient received bnt162b2 (BNT162B2), administered in arm right, administration date 30Dec2021 at 09:00 (Lot number: 33025BD) at the age of 44 years as dose 2, single for COVID-19 immunisation. Relevant medical history included: "None". There were no concomitant medications. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE; Lot Number: 33026BD; Anatomical location: Right arm), administration date: 09Dec2021 at 09:00, when the patient was 44 years old, for COVID-19 immunisation.  The following information was reported: LYMPHADENOPATHY (non-serious) with onset 31Dec2021 at 00:00, outcome "not recovered", described as "Swollen lymph nodes"; NAUSEA (non-serious) with onset 31Dec2021 at 00:00, outcome "not recovered", described as "Nausea"; VACCINATION SITE PAIN (non-serious) with onset 31Dec2021 at 00:00, outcome "not recovered", described as "Injection site pain"; HEADACHE (non-serious) with onset 31Dec2021 at 00:00, outcome "not recovered", described as "Headache"; MYALGIA (non-serious), ARTHRALGIA (non-serious) all with onset 31Dec2021 at 00:00, outcome "not recovered", and all described as "Muscle and joint pain". The events "Swollen lymph nodes", "Nausea", "Injection site pain", "Headache" and "Muscle and joint pain" were evaluated at the physician office visit. Therapeutic measures were not taken as a result of lymphadenopathy, nausea, vaccination site pain, headache, myalgia and arthralgia.  Additional information: Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Since the vaccination, the patient had not been tested for COVID-19.
Became dizzy. collapsed, then lost consciousness, possibly hit head  Called 911, transported to ER
Client c/o redness, swelling at site of injections L arm. Seen in emergency room diagnosed with cellulitis.
I had scratchy throat, nasal drip, congestion, mild dry cough, headaches, chest tightness, low grade fever of 99, joint pain, and fatigue. I tested positive for COVID-19. I was prescribed PAXLOVID and started to feel better after 2-3 days.
Pt vaccinated with DTP sustained severe & permanent injury to his entire body, including all extremities, he has lost use of his limbs, the ability to communicate and is severely retarded. Pt has been living in an institutional setting.
On Thursday evening I experienced a very loud ringing in my right ear. I also realized that I had gone deaf in the ear. Approximately 36 - 48 hours after, my hearing slowly returned, though I don't believe it's returned 100%. However, the ringing in my ear has persisted. It's now been over a week. There is no ringing at all in my left ear and never has been. I've never had ringing in either ear before.
runny nose; sneezing; This is a spontaneous report from a contactable consumer (patient) received from a Regulatory Authority. A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number and Expiration date was not reported), via an unspecified route of administration on an unspecified date in 2021 as a dose 2, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number and Expiration date was not reported), via an unspecified route of administration on an unspecified date as a dose 1, single for COVID-19 immunization. It was reported that, the caller received second dose today on an unspecified date, has runny nose and sneezing on an unspecified date in Mar2021. The temperature was normal but concerned about efficacy of vaccine. Any unaddressed medical questions referred or forwarded to Medical Information was reported as no. The outcome of the events was unknown.  No follow-up attempts are needed, information about lot/batch number cannot be obtained.
pt recv vax 7AUG96 & w/in 1wk of vax pt exp diarrhea, gassiness & abd pain;8AUG96 pt exp malaise, chills, diff taking a deep breath;pt tx w/APAP & rested;pt recovered rxn determined to be a poss rxn to vax w/MMR;
On internal audit, we discovered a patient received a vaccination held at refrigeration temperature for 38 days. Appropriate steps were taken to notify the state and are coordinating efforts to notify patients to repeat vaccination.
Pt went to ER with circumferential erythema and swelling with taut skin of (L) bicep. Erythema and warmth over left upper lateral, tender -> diagnosed sepsis.
This spontaneous report as received from a Health care worker pharmacy technician refers to a patient of unknown age and gender. On an unknown dates the patient was vaccinated with PNEUMOVAX 23 SDV lot # J009689 exp 29-JAN-2015 (dose and route not provided). Health care worker (pharmacy technician) stated that the patient may have received vaccines (doses and dose in series unspecified) that were improperly stored on 28-FEB-2014 at 9.5C for 50 minutes. No adverse effects reported. The outcome of incorrect product storage was unknown. This is one of several reports from the same source. Additional information has been requested.
having a little bit of like a flu, don't know if it's like a cold; having a little bit of like a flu, don't know if it's like a cold; This is a spontaneous report from a contactable consumer, the patient. This patient of unspecified age and gender received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine) via an unspecified route of administration on 17Dec2020 as a single dose for COVID-19 vaccination. The patient's medical history was not reported. On an unspecified date in Dec2020, the patient experienced having a little bit of like a flu, don't know if it's like a cold. Limited information was available. The clinical outcome of the flu like illness and a cold was unknown.   The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
My concern is the vaccine is rendering some antibiotics non effective. From the injection I had an infection that would not heal. I was put on two antibiotics AUGMENTIN and KEFLEX on 09/25/2022 for 5 days when the reaction started up. They put me on prednisone on 09/29/2022 which finally stopped the allergic reaction, I developed sore throat, fever and sinus infection. I had a COVID-19 test which was negative. I was diagnosed with strep and sinus infection.
48 yo male received JJ Covid 19 vaccine Lot #211A21A, 1st dose at 1625.  At 1628, while in the observation area, he stated "not feeling well and going to pass out."  ET, RN, stood in front of pt. , held his shoulders, called for assist,  place pulse ox on index finger, HR 44, O2 sat 97%,, pt passed out momentarily, skin cool/clammy to touch, diaphoretic.  At 1630 Pt transferred to WC and taken to room and transferred to guerney to lie down, with stand by assist.  Pt. stated "feeling better.'  Pt. stated "I usually pass out when getting shots" before receiving vaccine, stand by RN at pt side during vaccine, pt then walked to observation area with c/o dizziness.  Pt. reported he was  "reluctant about taking the vaccine, but needed it for work..Pt. denies CP, SOB, NV,  has no hx of diabetes, and said he did not eat or drink much today.
Pt vaccinated with DTP developed severe inconsolable crying for greater than 3 hrs.
Patches of extreme dryness started inside front lower lip and left and right upper lip where lip touches gums 04/03/21 to present. Pain and ulcer appeared inside lower lip/gum 04/09/21. Dry areas of lip tissue sticking to gums. Red left eye on 04/09/21 for about 4 days.  No itching or pain.  Joint pain in hands, knees,  and ankles starting approx. week after to present. Dry eyes and nasal passages for last week.  Saw Dentist on 04/09/21 for dry mouth patches and mouth pain. Miracle mouthwash prescribed. Mouth symptoms improved not eliminated to date.
Patient noticed a small "knot-like" mass at injection site, about the size of an eraserhead which seemed to scab over. Did not report any pain associated with mass.
This non-serious case was received from a health professional on 11 June 2008. A 29-year-old female patient, with a history of sulfa drug allergy and bipolar disorder, received an intramuscular left deltoid injection of ADACEL (lot number not known) on 21 April 2008. The same day, she also received an intramuscular right deltoid injection of Hepatitis B (manufacturer and lot number not known). Approximately 24 hours after vaccination, the patient complained of left shoulder pain. Three days later, the pain intensified, and at the time of the report was still ongoing. The patient had undergone unspecified testing, the results of which were not known by the reporter. She had been referred to an occupational medicine clinic for additional evaluation. Follow-up information was received 09 September 2008 from a health care professional. The patient had been vaccinated during a new hire physical and had received ADACEL, lot number C2899AA (expiration 09 May 2010) and a sixth dose of Hepatitis B, lot number AHBVB448AA (expiration 24 January 2010. The patient had not received any other vaccines during the four weeks prior to receipt of ADACEL and Hepatitis B vaccines. No additional information was provided at the time of the report.
Shortly after receiving FLU vaccine in left arm, start to develop mussel spasms in left shoulder, numbness in fingers, and weak grip strength in left hand. FLU vax site is same site as COVID 19 vax site.
Menveo was not mixed with conjugated  diluent but was mixed with sterile diluent and administered to patient.
Information has been received from a registered nurse concerning a 21 year old female who on 03-APR-2008 was inadvertently vaccinated with a dose of ZOSTAVAX (Merck) instead of VARIVAX (Merck). No adverse effect was reported. Additional information has been requested.
pt recv vax  4JAn99 & rt arm began to swell & also w/erythema & pruritus;21cm x 19cm per MD;
Pfizer-BioNTech COVID-19 Vaccine EUA: presented to emergency department with COVID-19 infection and leg pain. Diagnosed with deep vein thrombosis. Initiated anticogulation and continued as an outpatient. Discharged medically stable.
PATIENT REPORTED IMMEDIATE TOE TO NECK "IVP DYE TYPE WAVE OF WARM" RESOLVED IN FIRST 5 MINUTES OF OBS. HYDRATE  FULLY RESOLVED AT DISCHARGE.